In late March, when James Kidney retired as a trial lawyer at the Securities and Exchange Commission after 24 years, he gave a retirement speech to remember. The 66-year-old lawyer accused the agency of padding its enforcement statistics by targeting small time violators, while it politely tiptoes around executive suites. Rarely have such criticisms been stated so bluntly and publicly by an agency insider.
Although Kidney didn’t mention a particular case, one example he could have cited was the SEC’s lawsuit against Goldman Sachs & Co. over its Abacus investment vehicle. More than 2,000 pages of documents released by the SEC in response to an American Lawyer Freedom of Information Act request show Kidney’s frustrations over the SEC’s handling of that case, and the divisions within the agency over the investigation. (For a full timeline of the SEC’s deliberations, click here.)
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
